28.01.2019:
Digital Communication with Breast Cancer Patients. Real World Data Thanos P. Kosmidis¹, Paris A. Kosmidis² CareAcross UK¹, Hygeia Hospital Athens Greece² Background: CareAcross is a digital platform dedicated to support, inform and communicate with cancer patients. It, also, collects anonymously, medical information and creates real world data.
Material and Methods: In an effort to collect and analyze medical information from breast cancer patients regarding specific side effects in relation to their treatments and their tendency to receive supplements, we contacted 3499 women in United Kingdom. Among them, 279 patients had triple negative breast cancer (TNBC) and the rest 3220 other subtypes of breast cancer (non-TNBC). All information were anonymous.
Results: Different regimens were given either as adjuvant or as systemic treatments. AC treatment was given at 28% of TNBC and 9% at Non-TNBC patients. FEC-T at 29% vs 15%, FEC 15% vs 9%, Taxanes 37% vs 20% and platinum-based 12% vs 2% respectively. Trastuzumab was given at 12% of Non-TNBC. In the same group, hormonal treatment was given at 66% of patients. Toxicity is seen in the following table.
TNBC(%) Non-TNBC(%)
Fatigue 55 59
No appetite 18 10
Constipation 28 21
Peripheral neuropathy 26 14
Hot flushes 15 12
Taste problem 18 14
Mouth sores and dryness 38 26
Nausea 14 13
Diarrhea 6 10
Vitamins and supplements were taken as follow:
TNBC(%) Non-TNBC(%)
Turmeric 40 28
Vitamin-D 55 49
Vitamin-C 37 14
Flaxseed 33 23
Vitamin-B12 27 10
Multivitamin 27 15
Garlic 25 13
Magnesium 25 17
Calcium 25 23
Omega-3 23 17
Zinc 23 7
Selonium 23 6
Conclusions: In real world data, TNBC patients receive more toxic treatments due to the aggressive disease. Therefore, they experience more toxicities and tend to consumpt more vitamins and supplements.
